4 completed. 2 Phase 3, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow serdexmethylphenidate and dexmethylphenidate: new trials by email Literature Review of serdexmethylphenidate and dexmethylphenidate trials Research Report on serdexmethylphenidate and dexmethylphenidate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy, Safety and Tolerability of Oral AK0901 in Children With ADHD AK0901 capsule, Placebo - ADHD | Phase 3 | Completed | Shanghai Ark Biopharmaceutical Co., Ltd. | 55 | 2024-05-28 | 2026-06-22 |
| Duration and Efficacy of Azstarys on Adult ADHD Symptoms and Executive Function in Early Evening Serdexmethylphenidate/dexmethylphenidate - Adult Attention Deficit Hyperactivity Disorder | Phase 4 | Completed | NYU Langone Health | 29 | 2023-11-13 | 2025-07-29 |
| Study of SDX in Patients With Idiopathic Hypersomnia (IH) Serdexmethylphenidate, Placebo - Idiopathic Hypersomnia | Phase 2 | Completed | Zevra Therapeutics | 66 | 2022-12-28 | 2026-06-30 |
| KP415 Open-Label Safety Study in Children (6-12 Years of Age) With ADHD KP415 oral capsule - ADHD | Phase 3 | Completed | Zevra Therapeutics | 282 | 2018-03-13 | 2021-07-19 |
Attention Deficit Disorder with Hyperactivity (3) · Disorders of Excessive Somnolence (1) · Idiopathic Hypersomnia (1) · Mental Disorders (1) · Nervous System Diseases (1) · Sleep Wake Disorders (1)
Zevra Therapeutics (2) · NYU Langone Health (1) · Shanghai Ark Biopharmaceutical Co., Ltd. (1)
United States (3) · China (1)
Ann Childress, MD (1) · Christopher Drake, PhD (1) · Jingjing Hu (1) · Jun Qi (1) · Lenard Adler (1)